OREM, Utah, Sept. 18, 2013 (GLOBE NEWSWIRE) -- ActiveCare, Inc. (OTCBB:ACAR), the service leader in disease and diabetes management, announces that its Chief Strategy Officer, Michael Jones, was a keynote speaker at the Qualcomm Life Connect 2013 conference in San Diego. The theme of the conference focused on the disruption in the health care system and the role that solution providers such as ActiveCare are playing in transforming the market place using the Qualcomm Life Ecosystem.
ActiveCare's solution to the country's most expensive chronic disease, diabetes, gained national attention in August when Jones spoke on Disruption in Spite of Health Care Conformity. To quote Jones, "The ecosystem allows us to partner with the best in both technology and market strategy. This was a great opportunity for ActiveCare to present how these strengths have contributed to our phenomenal growth and improvement in the lives of our members. ActiveCare's relevance in this area grows each day as we continue to show cost savings to our customers and engage members in their own care."
ActiveCare's proprietary solution combines data analytics with real-time biometrics bringing clarity and visibility to the status and risk of members' health and cost of care. The company's CareCenter layers a human touch and monitoring component to traditional disease management by reaching out to members assisting in changing their behaviors. Assisting members to manage their disease increases compliance, improves the members' health while also reducing the risk of future catastrophic events.
ActiveCare, Inc. is the telehealth and personal emergency response solution leader. Headquartered in Orem, Utah, and publicly traded on the OTC Bulletin Board under symbol ACAR, ActiveCare is committed to providing consistent excellence in quality and safety, and friendly care for members and caregivers alike. To learn more about ActiveCare, Inc., visit the website at www.activecare.com.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including global economic conditions generally, regulatory uncertainty and economic pressure on the healthcare industry in particular, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with assimilating our recent acquisitions. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
CONTACT: Investor Contact: Adam Holdsworth, Managing Director ProActive Capital Group, LLC (646)-863-6341 Media Contact: Sandra Lee, Managing Director ProActive Capital Group, LLC (646)-863-6341